|
 |
DiovanThis page contains recent news articles, when available, and an overview of Diovan but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.The company highlighted strong growth from recently launched products, but the rise in sales of its best-selling drug Diovan was slower than for the ... Wall Street Journal UPDATE 1-Novartis invests $1 bln in China R&D plant - Nov 2, 2009 ...as China as they face slowing growth and loss of exclusivity on key products, including the Swiss group's top-selling blood pressure medicine Diovan. ... Reuters Ask Dr. H: Pain in feet could be neuropathic - Oct 19, 2009 I'm 85 years old, and take Synthroid, Diovan, Zocor, Coreg CR, Actonel, and a baby aspirin. Answer: It's difficult to say for certain why you've got ... Philadelphia Inquirer Diovan, Gleevec lift profit at Novartis - Oct 22, 2009 GENEVA — Novartis reported higher third- quarter profit yesterday and raised its full-year sales guidance as doctors prescribed more of its Diovan ... Business Day European approval for 3-in-1 version of Exforge - Oct 23, 2009 Exforge was first approved in Europe in 2007 as a 2-in-1 combination of Novartis' own angiotensin II receptor blocker Diovan (valsartan) and calcium channel ... Pharmafocus Novartis says drugs unit to outshine - Nov 9, 2009 Novartis loses patent protection on its top-selling blood pressure drug Diovan in 2012 -- rivals like Pfizer Inc (PFE.N: Quote, Profile, Research, ... Reuters A Jewish Mother in Your Cell Phone - Nov 11, 2009 20 patients using Diovan, a drug to lower blood pressure, had boosted 'compliance' with prescriptions from 30 per cent to 80 per cent after six months. ... Newsweek PBS listings in effect - Nov 2, 2009 Further additions to the PBS include Vytorin, which allows patients to have a combination of Ezetimibe with simvastatin in the one product; Co-Diovan ... Pharmacy News Novartis' Tasigna Seen Succeeding Top Drug Gleevec - Oct 20, 2009 Gleevec is Novartis' second-best selling drug after heart drug Diovan, and is expected to generate close to $4 billion in sales this year. ... Wall Street Journal Solid quarter for Novartis as firm waits for swine flu windfall - Oct 22, 2009 Novartis' biggest-seller was the blood pressure lowerer Diovan (valsartan), though sales increased just 1% to $1.46 billion, while sales of Glivec/Gleevec ... Pharma Times BIA, doctors back new discount drug program - Oct 23, 2009 The blood pressure-reducer Diovan retails for $90.63, but costs $72.39 with the card, a 20 percent discount. An independent check by NHBR of drug prices ... New Hampshire Business Review Commercial Insight: Antihypertensives - New fixed dose combinations unable to ... - Oct 30, 2009 Cozaar's and Diovan's patent expiries in the US are expected to alter the structure of the antihypertensive market dramatically. ... PRMinds (press release) UPDATE 1-Merck profit beats forecasts, boosted by Merial sale - Oct 22, 2009 VX) Diovan. But Januvia, a new type of diabetes pill, continued to make inroads with doctors and patients, with sales growing 30 percent to $491 million. ... Reuters Novartis invierte mil mdd en una planta para China - Nov 3, 2009 ...un crecimiento más lento y la pérdida de la exclusividad en productos clave, como en la exitosa medicina del grupo para la presión sanguÃnea Diovan. ... Milenio 诺å?Žåˆ¶è?¯å°†åœ¨ä¸å›½æŠ•èµ„10亿美元建è?¯ç‰©ç ”å?‘基地 - Nov 3, 2009 ...诺å?Žç‰åˆ¶è?¯å•†çƒè¡·äºŽå¼€å?‘ä¸å›½ç‰æ–°å…´å¸‚场,主è¦?åŽŸå› æ˜¯å…¶é?¢ä¸´å¢žé•¿æ”¾ç¼“以å?Šåœ¨å…³é”®äº§å“?上丧失排他性地ä½?,å…¶ä¸å°±åŒ…括诺å?Žåˆ¶è?¯æœ€ç•…销的é™?血压è?¯Diovan. 诺å?Žåˆ¶è?¯ç§°,还将投资2.5 ... 证券之星 ΥψηλότεÏ?α κÎÏ?δη για τη Novartis - Oct 21, 2009 Ï€Ï?ος τα πάνω τον στόχο για τις ετήσιες πωλήσεις της, εν μÎσω υψηλότεÏ?ης ζήτησης για τα σκευάσματα Diovan για την Ï…Ï€ÎÏ?ταση και Gleevec για τον καÏ?κίνο. ... Nαυτεμπορικη Novartis hält Ergebnis im 3Q bei leichtem Wachstum konstant - Oct 22, 2009 Der Pharmakonzern aus Basel wurde von schwächelnden Verkaufszahlen bei den profitablen Bestsellermedikamenten Diovan und Gleevec getroffen. ... FOCUS Online Novartis: l'UE homologue Exforge HCT pour traiter l'hypertension - Oct 22, 2009 Il s'agit d'un médicament combinant le Diovan (Valsartan), l'Amlodipine et l'Hydrochlorothiazid, ce qui permet une prise unique en un seul comprimé, ... Romandie.com Résumé du jour - Economie - Vendredi 23 octobre 2009 - Oct 23, 2009 Ce médicament du groupe pharmaceutique bâlois représente une combinaison du Diovan (Valsartan), du l'Amlodipine et de l'Hydrochlorothiazid. ... Romandie.com FOCUS/Novartis: le titre continue d'avancer après de solides chiffres T3 - Oct 22, 2009 L'évolution des ventes de Diovan et Gleevec l'a un peu déçu, mais cela a été compensé par la bonne performance des nouveaux produits. ... Romandie.com 诺å?Ž3å£åº¦å‡€åˆ©21亿美元 预计4å£åº¦å¢žé€ŸåŠ å¿« - Oct 22, 2009 ...诺å?Žå°†äºŽ2010年失去其最畅销è?¯ç‰©é™?压è?¯Diovan的专è?¥æ?ƒã€‚ 网易财ç»?10月22日讯æ?®æµ·å¤–媒体22日的报é?“称，瑞士医è?¯å·¨å¤´è¯ºå?Ž(Novartis AG)3å£åº¦å‡€åˆ©æ¶¦ä¸Šæ¶¨1%，至21亿美元， ... 网易 Novartis steuert 2009 auf Rekordergebnisse zu - Oct 22, 2009 ...der Umsatz durch die Nachfrage nach Kernprodukten wie dem Blutdruckmittel Diovan in lokalen Währungen um 8 Prozent auf 31341 Milliarden Dollar stieg. ... tt.com - Wo's Click macht 诺å?Žä¸‰å£åº¦å‡€åˆ©å¹´æ¯”仅增0.4%至21亿美元 - Oct 21, 2009 ...综å?ˆå¤–电10月22日报é?“，诺å?Ž(Novartis AG)22日报告其三å£åº¦å‡€åˆ©è¾ƒ08å¹´å?ŒæœŸ20.9亿美元仅增0.4%至21亿美元，低于分æž?师预测的21.6亿美元，畅销è?¯Diovan与Gleevec销售增速 ... 财讯 Novartis verhoogt omzetverwachting 2009 - Oct 22, 2009 De omzet van het bloeddrukverlagingsmiddel Diovan nam toe met 1% en bleef met een omzet van $1,46 mrd het best verkopende medicijn, gevolgd door het ... Financieele Dagblad Nestlé schwächelt wegen anstehendem Verkauf - Nov 12, 2009 Dem Unternehmen drohe aufgrund von Patentabläufen bei Diovan, Femara, Zometa und Glivec ein Ertragseinbruch. Novartis könne die Kosten aber nicht ... Cash Novartis: A H1N1 is segÃt - Oct 22, 2009 ...a magas vérnyomás kezelésére szolgáló Diovan, illetve a Gleevec rák ellenes készÃtmény, amelyek messze várakozások felett teljesÃtenek eddig az idén. ... ecoline.hu è²¡å ±è«¾è?¯è—¥å» Q3ç?²åˆ©æŒ?å¹³ ä¼°H1N1ç–«è‹—å?¯å¸¶ä¾†4-7億美元ç?²åˆ© - Oct 22, 2009 ...ç‘žå£«å¤§è—¥å» è«¾è?¯(Novartis AGï¹”NOVN-CH) 周四公佈第3 å£è²¡å ±ï¼Œå„˜ç®¡ç‡Ÿæ”¶æˆ?長，但ç?²åˆ©ä»?幾乎æŒ?å¹³ï¼›éƒ¨åˆ†å› ç‚ºç†±éŠ·è—¥å“?é™?血壓藥得安穩(Diovan) å?Šæ…¢æ€§éª¨é«“性白血病 ... 華視新聞 Novartis erhält EU-Zulassung für Bluthochdrucksenker-Kombi Exforge HCT - Oct 22, 2009 Beim Medikament handelt es sich um die Kombination von Diovan (Valsartan), Amlodipin und Hydrochlorothiazid in einer einzigen Tablette, ... Handelszeitung Online La UE aprueba un medicamento de Novartis contra la hipertensión - Nov 3, 2009 Con Diovan como base de esta nueva terapia, estamos seguros de que se convertirá en una importante opción de tratamientoâ€?. La presión arterial elevada, ... Infoperiodistas Novartis-Leukämiemittel Tasigna wirksamer als Gleevec - Oct 20, 2009 Gleevec verkauft sich derzeit am zweitbesten nach dem Blockbuster-Herzmittel "Diovan" und wird in diesem Jahr voraussichtlich nahezu 4 Mrd USD an Umsatz ... FOCUS Online ÃœBERBLICK/Unternehmen - 7.30 Uhr-Fassung - Oct 21, 2009 Der Pharmakonzern aus Basel wurde von schwächelnden Verkaufszahlen bei den profitablen Bestsellermedikamenten Diovan und Gleevec getroffen. ... FOCUS Online AKTIENFOKUS/Novartis-Aktien bauen Gewinne nach Q3-Zahlen aus - Oct 22, 2009 Die etwas enttäuschende Umsatzentwicklung von Schlüsselprodukten wie Diovan und Gleevec sei durch die gute Performance neuer Produkte ausgeglichen worden. ... NZZ Online Schweinegrippe lässt bei Novartis die Kassen klingeln - Oct 22, 2009 So sei etwa das Umsatzplus des Blutdrucksenkers Diovan sowie des Leukämiemedikaments Glivec eher mager ausgefallen, bemängelten die Analysten der Credit ... Reuters Deutschland (Pressemitteilung) Novartis: fatturato stabile, utile netto in calo su nove mesi - Oct 22, 2009 Nel campo dei farmaci contro l'ipertensione arteriosa, il medicinale di punta Diovan ha generato ricavi per 4,4 miliardi di dollari (+5% in valute locali). ... Swissinfo Dirk Scheringa heeft volgens Pieter Lakeman minstens EUR45 miljoen weggesluisd - Oct 22, 2009 De omzet van het bloeddrukverlagingsmiddel Diovan nam toe met 1% en bleef met een omzet van $1,46 miljard het best verkopende medicijn, gevolgd door het ... Beurs.nl Novartis boekt winst van 2,1 miljard in derde kwartaal - Oct 22, 2009 De best verkopende medicijnen van Novartis zijn het bloeddrukverlagende middel Diovan en het kankermedicijn Gleevec. De winstverwachting van Novartis blijft ... DeAandeelhouder.nl Novartis "buy" - Oct 22, 2009 Allerdings seien auf Produktniveau Diovan (US-Wachstum in Lokalwährung -7%) aufgrund des sich verlangsamenden Marktes und bei Gleevec (Wachstum außerhalb ... newratings.de Analysten sind bullish auf Novartis - Oct 22, 2009 Die etwas enttäuschende Entwicklung von Schlüsselprodukten wie Diovan und Gleevec wurde durch die gute Performance neuer Produkte ausgeglichen. ... Cash Novartis "outperform" - Oct 22, 2009 Novartis weise bis 2015 nach wie vor eines der besten Wachstumsprofile, sowohl bei Umsatz als auch Ergebnis je Aktie, auch wenn Femara in 2011 und Diovan in ... newratings.de Europa-Börsen schließen schwach - Optimismus hält dennoch an - Oct 22, 2009 Die niedriger als erwartet ausgefallenen Umsätze mit den Schlüssel-Präparaten "Diovan" und "Gleevec" seien nicht tragisch und spiegelten lediglich die ... Märkische Allgemeine Hugin-News: Novartis International AG - Oct 21, 2009 Auch in Europa erzielte Diovan nach wie vor ein starkes Wachstum. Dort verzögert Jahreshälfte 2010. In den USA konnte Diovan (+3%) trotz des das ... Berliner Morgenpost Novartis "buy" - Oct 29, 2009 Novartis Pharmaceuticals werde durch die Generikaproduktion von so wichtigen Medikamenten wie Diovan, Zometa, Femara und Exelon belastet werden. ... newratings.de Novartis sees sales of hypertension drug Diovan exceeding 4 bln usd... - Oct 18, 2005 ZURICH (AFX) - Novartis AG said its hypertension drug Diovan will likely exceed the 4 bln usd sales mark in 2006. Diovan is 'on track' to overshoot the 4 ... Forbes Novartis says Japan study shows Diovan benefits - Apr 27, 2007 ZURICH, April 27 (Reuters) - Novartis AG's (NOVN.VX) blood pressure drug Diovan cut incidence of strokes and cardiovascular events by about 40 percent in an ... Reuters Teva wins tentative US OK for generic Diovan - Jun 12, 2008 NEW YORK, June 12 (Reuters) - US regulators have granted tentative approval to Teva Pharmaceutical Industries Ltd's (TEVA.O) generic form of Novartis AG's ... Reuters Novartis Profit Rises 4.1% on Diovan, Gleevec Sales - Jul 17, 2006 By Carey Sargent. July 17 (Bloomberg) -- Novartis AG, Europe's third-largest drugmaker, said second-quarter profit rose 4.1 percent as sales of the heart ... Bloomberg Novartis: FDA OKs Diovan for treatment of high blood pressure in... - Dec 3, 2007 SAN FRANCISCO (Thomson Financial) - Novartis AG's Novartis Pharmaceuticals Corp. said Monday the Food and Drug Administration approved Diovan for the ... Forbes Novartis' Diovan gets EU marketing authorisation to treat heart... - Jun 13, 2005 ZURICH (AFX) - Novartis AG said its drug Diovan, which is already approved to treat heart attack survivors, has now received EU marketing approval for the ... Forbes Novartis Second-Quarter Net Rises 17% on Diovan Sales - Jul 17, 2008 By Eva von Schaper. July 17 (Bloomberg) -- Novartis AG, the maker of the Femara breast tumor treatment, said second-quarter profit rose 17 percent, ... Bloomberg Novartis says US grants extra Diovan exclusivity - Aug 10, 2007 ZURICH, Aug 10 (Reuters) - US regulators have given Novartis (NOVN.VX) an extra six months marketing exclusivity for the Swiss company's Diovan blood ... Reuters Novartis' Diovan receives EU approval for treatment of heart attack … - May 9, 2005 BASEL (AFX) - Novartis AG announced it has successfully completed the EU mutual recognition procedure in 14 countries for Diovan (valsartan) for the ... Forbes Novartis profit rises on Diovan, Glivec sales - Jan 18, 2007 AP. BASEL, Switzerland – Swiss pharmaceutical maker Novartis AG said Thursday its fourth-quarter profit rose 23 percent on strong sales of its top-selling ... Toronto Star Novartis prepares for looming loss of diovan patent - Nov 19, 2008 By Anita Greil. ZURICH (MarketWatch) -- Novartis AG is working on several drugs that will combine its new heart medicine Rasilez and another drug in a ... MarketWatch Novartis Profit Rises 11% on Diovan, Gleevec Sales - Apr 23, 2007 By Eva von Schaper. April 23 (Bloomberg) -- Novartis AG, Europe's third-largest drugmaker, said first-quarter profit rose as the company paid less than ... Bloomberg FDA Approves Higher Dose Formulations Of Diovan HCT(R) (valsartan/ … - May 2, 2006 The US Food and Drug Administration (FDA) approved two new, higher dose formulations of the high blood pressure medication Diovan HCT(R) ... Medical News Today - Medical News Today (press release) Novartis says new Diovan data show post heart attack benefits - Sep 6, 2005 ZURICH (AFX) - Novartis AG said new data show its Diovan drug reduces the chance of cardiovascular events that may be caused by clogged arteries ... Forbes Diovan(R) (valsartan) the First Blood Pressure Medication in a Large-... - May 19, 2006 NEW YORK, May 19 /PRNewswire/ -- Diovan lowered the level of the inflammatory marker high sensitivity C-reactive protein (hsCRP), independently of its ... Free with registration - PR Newswire - AccessMyLibrary.com Novartis First-Quarter Profit Rises on Diovan Sales - Apr 21, 2008 By Eva von Schaper. April 21 (Bloomberg) -- Novartis AG, Switzerland's second- largest drugmaker, said first-quarter profit increased 10 percent on higher ... Bloomberg Novartis Delivers Strong Start to 2006 in First Quarter with Excellent... - Apr 24, 2006 In cardiovascular, Diovan ranks No. 1 in its class. ... In the US, net sales rose 15% to USD 2.1 billion, driven by Diovan, Lotrel and Zelnorm as well as ... primezone.com Ranbaxy gets tentative USFDA nod for generic Diovan - Nov 2, 2007 New Delhi, Nov. 1 Ranbaxy Laboratories said it has received tentative approval from the US Food and Drug Administration to make and sell the hypertension ... Hindu Business Line Single-Pill Combinations Diovan HCT and Exforge Approved in US As … - Aug 4, 2008 EAST HANOVER, NJ, Aug. 4 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved two single-pill combination medications, Diovan HCT(R) ... RedOrbit Tekturna Approval Pumps Up Novartis - Mar 6, 2007 Diovan, a member of the angiotensin-receptor blocker class, produced $4.22 billion in sales last year. Lotrel, which contributed $1.35 billion to revenue, ... TheStreet.com - TheStreet.com (subscription) US asks for more data on Novartis cancer drug - Nov 19, 2008 As part of its drive to cushion loss of Diovan sales, Novartis expects to file a single pill combination of blood pressure drugs Tekturna and Diovan in the ... Reuters Novartis to seek OK on two drugs - Sep 21, 2005 Novartis is also trying to squeeze sales out of Diovan by getting approval for additional uses. ''The scientific data they've given so far has raised as ... Boston Globe Sales Advance at Novartis - Jan 19, 2006 Net sales in the US climbed 14% to $2.2 billion, fueled by growth in the drugs Diovan, Lotrel, Gleevec, Femara and Zelnorm. In Europe, net sales fell 2% in ... TheStreet.com - TheStreet.com (subscription) New Drug Combo Fights High Blood Pressure - Jul 20, 2007 However, taking the two drugs Diovan and Tekturna, "might not be the first ... The two drugs used in the study were valsartan (Diovan), which blocks the ... Washington Post Novartis posts 32% net profit gain - Oct 20, 2008 Drug sales rose 14 percent in US dollar terms to $6.71 billion, just ahead of forecasts and underpinned by top-sellers Diovan and its cancer drug Glivec. ... New York Times EU approves Diovan to treat people with heart failure - Jun 18, 2005 Novartis announced today that it has successfully completed an EU type 2 variation procedure in 14 countries for Diovan® (valsartan) for the treatment of ... i-newswire.com FDA Approves Higher Dose Formulations of Diovan HCT(R) (valsartan/ … - Jan 5, 2006 EAST HANOVER, NJ, May 1 /PRNewswire/ -- The US Food and Drug Administration (FDA) approved two new, higher dose formulations of the high blood pressure ... Euro am Sonntag Novartis to Sell Exforge in US - Jun 21, 2007 Exforge combines the company's Diovan and the ingredient in Pfizer's(PFE Quote) Norvasc. The FDA's conditional approval in December took into account ... TheStreet.com - TheStreet.com (subscription) Laxatives not the answer - Oct 24, 2005 I take Diovan for high blood pressure. Would guggul pose a risk? ... Guggul probably would not interact with your Diovan, but given its questionable ... Los Angeles Times Novartis Q2 misses consensus as Chiron charges weigh; sees record FY ... - Jul 17, 2006 In Europe, net sales rose 4 pct with market share gains for Diovan and good sales of Glivec partially offset by price cuts imposed by government healthcare ... Forbes Novartis Says Net Rose 18% on Diovan, Sees Slowdown - Jul 17, 2007 By Eva von Schaper. July 17 (Bloomberg) -- Novartis AG, Switzerland's largest drugmaker, said second-quarter profit rose 18 percent on sales of the Diovan ... Bloomberg Novartis Hedges Its Bets - Sep 23, 2005 ..."It looks better than Diovan" in terms of efficacy, Vasella says of aliskiren, comparing it with the company's big-selling Diovan hypertension drug. ... Forbes Novartis Delivers Dynamic Sales and Earnings Growth in the First Nine... - Oct 19, 2006 Diovan expanded its leadership position in the US, improving its share of ... Sales of Co-Diovan (a combination with a diuretic) advanced at a rapid pace in ... CNNMoney.com Novartis committed to Alcon, despite crisis - Dec 5, 2008 ...but the sector faces looming threats from copy-cat generic competition -- Novartis's own top selling blood pressure drug Diovan loses patent protection ... Reuters Other brand name: Diovan HCT - Dec 1, 2005 Diovan is one of a new class of blood pressure medications called angiotensin II receptor antagonists. Diovan works by preventing the hormone angiotensin II ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Novartis says combination of Tekturna/Diovan more effective than … - Mar 26, 2007 ZURICH (AFX) - Novartis AG said results from a study involving 1800 patients show that those taking both hypertension pressure drugs Tekturna and Diovan saw ... Forbes Novartis' Exforge more effective than only amlodipine - Jul 28, 2008 Exforge, which is a single-pill combination of high blood pressure medicines Diovan and amlodipine, also significantly reduced blood pressure across ... Reuters India Novartis gets FDA nod for blood-pressure pill - Dec 22, 2006 Both Norvasc and Diovan are the top-selling therapies in their respective categories. Norvasc had US sales of $2.6 billion in 2005, while Diovan racked up ... Medical Marketing & Media - Medical Marketing and Media Vaccines pump up Novartis 1Q profits; US sales down - Apr 21, 2008 Hypertension drug Diovan accounted for $1.4 billion (890 million euros) on overall drug sales of $6.26 billion (3.97 billion euros). ... USA Today Novartis set to unveil job cuts - Dec 12, 2007 The patent for blood pressure drug Diovan, one of Novartis's most important drugs, is running out. The turnover of the drug grew by 15 per cent to $4.2bn in ... MarketWatch Profits Surge for Novartis - Apr 24, 2006 Among its major products, Novartis said sales of its blood-pressure drug Diovan rose 16% to $939 million. The cancer treatment Gleevec gained 18% to $559 ... TheStreet.com - TheStreet.com (subscription) TheStreet.com Staff Reporter - Apr 21, 2005 Strong performers included the cancer drugs Gleevec, Femara and Zometa, the blood pressure medication Diovan and the eczema drug Elidel. ... TheStreet.com - TheStreet.com (subscription) Swiss shares close lower on US weakness, led by Novartis post results... - Apr 24, 2006 Key drug Diovan generated sales of 939 mln sfr and Glivec 550 mln, both short of expectations of 978 mln sfr and 608 mln respectively, he said. ... Forbes Swiss shares move lower in quiet morning trade on profit-taking - May 9, 2005 Novartis decreased 0.45 sfr to 59.25, with news that it has successfully completed the EU mutual recognition procedure for Diovan for the treatment of heart ... Forbes FDA eyes new use for Diovan.(Focus)(Novartis AG's valsartan is … - Jan 21, 2008 HANOVER, NJ -- Diovan (valsartan), an angiotensin receptor blocker, or ARB, has been approved after a priority review by the Food and Drug Administration ... Free with registration - Chain Drug Review - AccessMyLibrary.com Novartis Posts Record Earnings for 10th Year - Jan 19, 2007 Overall sales rose 16 percent, to $10.05 billion, from $8.66 billion in the last quarter of 2005, with help from Diovan, a hypertension drug, and the cancer ... New York Times Novartis 1Q earnings driven by Gleevec, Diovan - Apr. 21, 2006 - Apr 21, 2006 By Aaron Smith, CNNMoney.com staff writer. "Both the European and US companies are using cost-cutting as a means of controlling EPS growth, but it's clear ... CNNMoney.com Novartis' Diovan OK'd for a new use.(FDA approves Diovan) - Aug 29, 2005 EAST HANOVER, NJ -- The Food and Drug Administration has approved Diovan as a treatment for reducing cardiovascular deaths in patients who are at high risk ... Free with registration - Chain Drug Review - AccessMyLibrary.com Leading Blood Pressure Medication Diovan with Diuretic Reduces Key … - Jun 5, 2008 ...(HealthNewsDigest.com) - Basel, June 5, 2008 — A study published in the latest issue of Hypertension demonstrates that the leading angiotensin receptor ... DentalPlans.com Purchase Diovan - Oct 19, 2007 Union, the main body that regulates pharmaceuticals is the study of pharmacology has also changed substantially. It has become possible, Purchase Diovan ... Sokwanele Diovan® receives EU approval for the treatment of heart attack... - May 10, 2005 ...(I-Newswire) - Novartis announced today that it has successfully completed the EU Mutual Recognition Procedure ( MRP ) in 14 countries for Diovan® ... i-newswire.com Ranbaxy Gets Tentative Backing for Copy of Novartis' Diovan - Oct 29, 2007 By Eva von Schaper. Oct. 29 (Bloomberg) -- Ranbaxy Laboratories Ltd. won tentative approval to sell a copy of Novartis AG's best-selling Diovan high-blood ... Bloomberg Markets; Novartis Profit Up Despite Deal Costs - Jul 18, 2006 Swiss drug maker Novartis said Monday that second-quarter profit climbed 4.1% as sales of its heart pill Diovan and cancer medicine Gleevec offset costs ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Single Pill Combinations Diovan HCT® And Exforge® Approved In US As … - Aug 9, 2008 The US Food and Drug Administration (FDA) has approved two single-pill combination medications, Diovan HCT® (valsartan and hydrochlorothiazide) and Exforge® ... Medical News Today - Medical News Today (press release) Novartis, Morphosys in $600 mln antibody deal - Dec 2, 2007 ...keen to do deals and cash in with a simpler exit strategy. Novartis' own top seller, blood pressure drug Diovan, goes off patent in 2012. Continued... Reuters Discount Diovan Online - Jul 6, 2007 European Pharmacopoeia. Pharmacology as Discount Diovan Online chemical science is practiced by pharmacologists. Subdisciplines include clinical ... Sokwanele Health Canada Approves Diovan (valsartan) to reduce cardiovascular … - Sep 26, 2005 Novartis Pharmaceuticals Canada Inc. announced today that Health Canada has approved PrDiovan* (valsartan) for a new indication to reduce cardiovascular ... Medical News Today - Medical News Today (press release) New Data Show Tekturna And Diovan Used Together Provide Additive … - Jul 23, 2007 Results from a new study involving high blood pressure patients taking Tekturna (aliskiren) and Diovan (valsartan) were published today in The Lancet. ... Medical News Today - Medical News Today (press release) Novartis says Exforge 'successful' in trials vs single medicines - May 21, 2007 ...most commonly prescribed high blood pressure medicines, angiotensin receptor blocker valsartan (Diovan) and the calcium channel blocker amlodipine. ... Forbes RPT Novartis posts in-line Q4 net on continued pharma strength; sees ... - Jan 18, 2007 ...from 1.352 bln last year, citing continuing strong growth particularly in its pharma division, driven by best-selling brands Diovan, Gleevec and Lotrel. ... Forbes PREVIEW-Novartis, Sanofi try to show the drugs are working - Sep 11, 2007 ...raising anxieties about Novartis's all-important hypertension franchise, which faces a major hurdle in 2012 when top-seller Diovan goes off patent. ... Reuters … : FDA Approves Higher Dose Formulations of Diovan HCT(R) (valsartan/... - May 1, 2006 FDA Approves Higher Dose Formulations of Diovan HCT(R) (valsartan/hydrochlorothiazide) for Treatment of High Blood Pressure. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research J&J, Lilly Cited by US Over Promotional Materials - Sep 26, 2008 The FDA questioned materials from Novartis AG about Focalin XR and Diovan, Mallinckrodt Inc. for Methylin, and Shire Ltd. about Adderall XR. Bloomberg Novartis Garners Pediatric Exclusivity for Diovan - Aug 20, 2007 The FDA has granted Diovan pediatric exclusivity based on studies conducted in children with high blood pressure, Novartis announced. ... FDA news - FDA news (subscription) Hypertension drug launched - Oct 10, 2007 A NEW first-line anti-hypertension drug, Diovan, has been launched in Uganda. ... Diovan is produced by Norvatis Pharma Services, a Switzerland-based drug ... New Vision International Approvals: Diovan, Velcade, Macugen - May 16, 2005 May 16, 2005 — The European Commission has approved new indications for valsartan tablets and bortezomib for injection, allowing their use to reduce the ... Medscape Diovan COD - Sep 18, 2007 Hill. ISBN 0-07-312275-0. 2. ^ abcde Newton, David; Alasdair Thorpe, Chris Otter Diovan COD Revise A2 Chemistry. Heinemann Educational Publishers, page 1. ... Sokwanele … Marketing Exclusivity For The High Blood Pressure Medicine Diovan(R... - Aug 11, 2007 Diovan is the only agent in its class (angiotensin receptor blocker or ARB) ... Clinical studies have shown that Diovan effectively lowers blood pressure. ... Medical News Today - Medical News Today (press release) Order Diovan COD - Sep 29, 2007 ...other companies from producing that medicine for a certain allocation of time.[2] [edit] Drug legislation and safety In the United States, the Food and Drug ... Sokwanele Diovan 30 Pills X 80 Mg - May 26, 2007 ...will ever reach the open market, this is an expensive way of doing things, costing Diovan 30 Pills X 80 Mg of Dollars. To recoup this outlay pharmaceutical ... Sokwanele Diovan Achieved 40% Reduction In Stroke And Cardiovascular Events In ... - Apr 29, 2007 New findings from the independent Jikei Heart Study, published today in The Lancet[1], show that adding the blood pressure lowering medication Diovan to ... Medical News Today - Medical News Today (press release) Buy Diovan Online - Nov 10, 2007 List of drugs [edit] Footnotes 1. ^ ab Buy Diovan Online Hinter; Barbara Buy Diovan Online (2005). Pharmacology: An Introduction. Boston: McGraw Hill. ... Sokwanele Novartis to invest US$700m in S'pore biotech plant - Oct 29, 2007 Expected to be fully operational by 2009, the plant will employ 160 people and make products including the Diovan heart drug and Tekturna for hypertension. ... AsiaOne Diovan from Canadian Pharmacy - Nov 30, 2007 ...that offer a degree in pharmacology or in related disciplines. * University of British Columbia - B.Sc in Pharmacology * Brody School of Medicine at East ... Sokwanele Buy Diovan COD - Jul 5, 2007 ...effect or desired outcome.[1] The safety and effectiveness of prescription drugs in Buy Diovan COD US is regulated by the European Union, the main body that ... Sokwanele Press Release: Diovan(R) (valsartan) the First Blood Pressure... - May 19, 2006 Diovan(R) (valsartan) the First Blood Pressure Medication in a Large-Scale Clinical Trial to Lower C-Reactive Protein, an Important Marker of Inflammation. Pay-Per-View - PR Newswire - HighBeam Research Ranbaxy drops patent challenge - Sep 23, 2007 Diovan is Novartis' biggest seller; it notched up sales of $2.4 billion in the first half of the year accounting for 20 per cent of the company's sales. Hindu Business Line Press Release: FDA Approves Diovan(R) for Treatment of High Blood … - Dec 3, 2007 FDA Approves Diovan(R) for Treatment of High Blood Pressure in Children. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Maine v. Astrue, No. 4:07CV1074 CDP (EDMo. 05/27/2008) - May 27, 2008 Dr. Myers noted that Maine was previously taking Diovan, but that he had not taken ... Dr. Buvat placed Maine on Diovan 320/25. He stopped Maine's usage of ... $2.95 - U.S. District Court, Eastern District... - VersusLaw Heart attack survival rates rising, thanks to meds - Mar 24, 2007 Growing use of Pfizer Inc.'s Lipitor for cholesterol, Novartis AG's Diovan for high blood pressure and other similar drugs has helped decrease deaths that ... New York Daily News … ' Diovan OK'd for a new use.(FDA approves Diovan) - Chain Drug... - Aug 29, 2005 Novartis' Diovan OK'd for a new use.(FDA approves Diovan) ... find Chain Drug Review articles. EAST HANOVER, NJ -- The Food and Drug Administration has ... Pay-Per-View - Chain Drug Review - HighBeam Research FDA Approves Diovan(R) (Valsartan) to Reduce Cardiovascular Death in ... - Aug 3, 2005 Diovan can now be prescribed in a broader range of heart failure patients ... "Millions of patients already rely on Diovan to help them get to goal and ... $4.95 - PR Newswire - ECNext … powerful blood pressure-lowering efficacy with Diovan®/Co-Diovan® ... - Jun 20, 2005 50.9% amlodipine 10mg; p<0.05 for Diovan + HCTZ 160/25 mg vs. amlodipine 10mg). ... The overall program has shown Diovan to effectively help patients get to ... Pay-Per-View - Hugin Press Release - Factiva, from Dow Jones Study shows Diovan reduced urinary protein excretion in patients with... - Nov 13, 2006 In patients with Hypertension.aspx">high blood pressure and type 2 diabetes, the blood pressure-lowering medication Diovan (valsartan) significantly reduced ... News-Medical.net Press Release: Single-Pill Combinations Diovan HCT and Exforge … - Aug 4, 2008 Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Valsartan the First Blood Pressure Medication in a Large-Scale... - May 26, 2006 The study also showed that Diovan and Diovan HCT helped a significant number of ... In Val-MARC, the reduction observed with Diovan on hsCRP levels was ... DG News Diovan HCT and Exforge approved in US as first-line treatments for... - Apr 8, 2008 The FINANCIAL -- The US Food and Drug Administration (FDA) has approved two single-pill combination medications, Diovan HCT (valsartan and ... The FINANCIAL FDA OKs higher dose of Novartis' Diovan.(Licensing of Antihypertensive... - May 8, 2006 The US Food and Drug Administration has approved two new, higher dose formulations of Swiss drug major Novartis' medication for elevated blood pressure, ... $4.95 - Pharma Marketletter - ECNext Novartis' one-pill drug combos Diovan HCT and Exforge won FDA … - Sep 1, 2008 Novartis' one-pill drug combos Diovan HCT and Exforge won FDA approval.(Pipeline) ... find Medical Marketing & Media articles. Novartis' one-pill drug ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Novartis, Ranbaxy argue over Diovan patent - Aug 20, 2007 Meanwhile, Novartis is suing the Indian generics giant Ranbaxy Laboratories over a copycat version of Diovan. Novartis says the blood pressure med--its top ... FiercePharma Study Shows Valsartan Reduced Urinary Protein Excretion in Patients … - Nov 20, 2006 The findings were from a study called DROP (Diovan Reduction Of Proteinuria), ... "DROP found that high doses of Diovan provided a greater reduction in ... DG News What is the difference between Diovan HCT and Accupril? - Dec 28, 2008 I take Diovan HCT 80mg/ 12.5 mg......my doctor gave me a sample of Accupril 20mg. Are they the same thing? Diovan HCTZ is a combination of Diovan (generic ... HealthCentral.com Teva Gets Tentative OK for Generic Diovan - Jun 23, 2008 The FDA has granted tentative approval to Teva's ANDA to market generic 40-, 80-, 160- and 320-mg strength tablets of hypertension treatment Diovan, ... FDA news - FDA news (subscription) Repeat - Novartis Announces Efficacy Data on New Investigational High... - May 17, 2006 Val-MARC evaluates the effects of Diovan on high sensitivity C-reactive protein (hsCRP), an important marker for inflammation. In total, there will be more ... RedOrbit Novartis cuts jobs despite profit - Oct 21, 2008 ...to $950 million to lead gains in the oncology division. Another best-seller, the blood-pressure medication Diovan, increased 9 percent to $1.4 billion. $2.95 - Miami Herald - NewsBank Rx plan expected be help to 500G in Mass. - Jan 12, 2005 ...at least 25 percent on 275brand-name drugs - including Pfizer's popular cholesterol-lowering Lipitor and Novartis's Diovan blood pressure treatment. ... Pay-Per-View - Boston Herald - ProQuest Archiver Novartis highlights strong R&D pipeline, plans for multiple new … - Nov 28, 2006 In another new study, the combination of Tekturna and Diovan showed a significant additive reduction in blood pressure compared to Diovan alone, ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com … heart attack.(Novartis AG's developed Diovan recieves European... - Jul 1, 2005 Diovan has successfully completed the EU mutual recognition procedure in 14 countries for the treatment of heart-attack survivors. ... Pay-Per-View - Med Ad News - Factiva, from Dow Jones … Release: Leading Blood Pressure Medication Diovan(R) With Diuretic... - Jun 5, 2008 Leading Blood Pressure Medication Diovan(R) With Diuretic Reduces Key Sign of Artery Ageing Which is Linked to Risk of Heart Attack and Stroke. from PR ... Pay-Per-View - PR Newswire Europe - HighBeam Research Novartis expands on Rasilez news - Aug 29, 2007 Top-seller Diovan (valsartan) is also manufactured at the site, ... Diovan has played a starring role in Novartis' portfolio and helped push growth at the ... In-PharmaTechnologist.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
